A biopharmaceutical leader, inspired by the needs of people living with severe diseases
At UCB Australia, we believe everyone deserves to live the best life that they can – as free as possible from the challenges and uncertainty of disease. We act with focus and care to help improve the lives of the people we serve, now and into the future. Our patients inspire our research and development across neurology, immunology, and other areas where our expertise, innovation and ambition are aligned with unmet needs. Our work is never done – because we strive to find new ways to deliver solutions, peace of mind and opportunity to people living with severe diseases.
Connections shape our understanding
We build strong connections with patients, caregivers, and healthcare professionals, engaging in an ongoing dialogue that shapes our understanding and inspires purposeful innovation. Through listening and collaboration, we deliver innovative and differentiated solutions, which manifests as moments celebrated, dreams pursued and simple pleasures enjoyed.
Culture of collaboration
We are dedicated individuals who see science as a means of expressing humanity. Attracting bright minds and big hearts, we encourage our culture of collaboration and curiosity, valuing diverse perspectives and backgrounds. From our headquarters in Belgium to nearly 40 countries worldwide, we push boundaries with purpose to make a tangible impact on those affected by severe diseases.
Innovation creates patient value
We embrace new tools, technologies, and partnerships that connect us with the people we serve, enabling us to understand them at a deeper level, and let us see where promising innovation can create valuable health solutions. We are driven to explore the furthest reaches of scientific and medical knowledge to help solve unmet needs.
Our commitment to patients
Each day, we see the person and not just the disease. We listen with intent, we question our preconceptions, we reflect on our work and its impact, we innovate with agility and purpose, and we pursue what’s right for those who live with severe diseases. Our commitment to patient value is unwavering, and we remain focused on delivering impactful, purposeful innovations that help improve lives, now and into the future.
AU-OT-2400020. May 2025.